These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30682224)

  • 1. Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate-binding region.
    Kelly M; Park M; Mihalek I; Rochtus A; Gramm M; Pérez-Palma E; Axeen ET; Hung CY; Olson H; Swanson L; Anselm I; Briere LC; High FA; Sweetser DA; ; Kayani S; Snyder M; Calvert S; Scheffer IE; Yang E; Waugh JL; Lal D; Bodamer O; Poduri A
    Epilepsia; 2019 Mar; 60(3):406-418. PubMed ID: 30682224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the First GNAO1-Related Neurodevelopmental Disorders Caregiver Survey.
    Axeen E; Bell E; Robichaux Viehoever A; Schreiber JM; Sidiropoulos C; Goodkin HP
    Pediatr Neurol; 2021 Aug; 121():28-32. PubMed ID: 34139551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of movement disorders in GNAO1 encephalopathy: in-depth phenotyping and case-by-case analysis.
    Kim SY; Shim Y; Ko YJ; Park S; Jang SS; Lim BC; Kim KJ; Chae JH
    Orphanet J Rare Dis; 2020 Dec; 15(1):343. PubMed ID: 33298085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse models characterize GNAO1 encephalopathy as a neurodevelopmental disorder leading to motor anomalies: from a severe G203R to a milder C215Y mutation.
    Silachev D; Koval A; Savitsky M; Padmasola G; Quairiaux C; Thorel F; Katanaev VL
    Acta Neuropathol Commun; 2022 Jan; 10(1):9. PubMed ID: 35090564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent GNAO1 Mutations Associated With Developmental Delay and a Movement Disorder.
    Menke LA; Engelen M; Alders M; Odekerken VJ; Baas F; Cobben JM
    J Child Neurol; 2016 Dec; 31(14):1598-1601. PubMed ID: 27625011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dystonia as a prominent presenting feature in developmental and epileptic encephalopathies: A case series.
    Dzinovic I; Škorvánek M; Necpál J; Boesch S; Švantnerová J; Wagner M; Havránková P; Pavelekova P; Haň V; Janzarik WG; Berweck S; Diebold I; Kuster A; Jech R; Winkelmann J; Zech M
    Parkinsonism Relat Disord; 2021 Sep; 90():73-78. PubMed ID: 34399161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenomenology and clinical course of movement disorder in GNAO1 variants: Results from an analytical review.
    Schirinzi T; Garone G; Travaglini L; Vasco G; Galosi S; Rios L; Castiglioni C; Barassi C; Battaglia D; Gambardella ML; Cantonetti L; Graziola F; Marras CE; Castelli E; Bertini E; Capuano A; Leuzzi V
    Parkinsonism Relat Disord; 2019 Apr; 61():19-25. PubMed ID: 30642806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GNAO1-associated epileptic encephalopathy and movement disorders: c.607G>A variant represents a probable mutation hotspot with a distinct phenotype.
    Arya R; Spaeth C; Gilbert DL; Leach JL; Holland KD
    Epileptic Disord; 2017 Mar; 19(1):67-75. PubMed ID: 28202424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GNAO1 Mutations Affecting the N-Terminal α-Helix of Gαo Lead to Parkinsonism.
    Solis GP; Larasati YA; Thiel M; Koval A; Koy A; Katanaev VL
    Mov Disord; 2024 Mar; 39(3):601-606. PubMed ID: 38358016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype-phenotype correlation and treatment effects in young patients with
    Thiel M; Bamborschke D; Janzarik WG; Assmann B; Zittel S; Patzer S; Auhuber A; Opp J; Matzker E; Bevot A; Seeger J; van Baalen A; Stüve B; Brockmann K; Cirak S; Koy A
    J Neurol Neurosurg Psychiatry; 2023 Oct; 94(10):806-815. PubMed ID: 37225406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highlighting the Dystonic Phenotype Related to GNAO1.
    Wirth T; Garone G; Kurian MA; Piton A; Millan F; Telegrafi A; Drouot N; Rudolf G; Chelly J; Marks W; Burglen L; Demailly D; Coubes P; Castro-Jimenez M; Joriot S; Ghoumid J; Belin J; Faucheux JM; Blumkin L; Hull M; Parnes M; Ravelli C; Poulen G; Calmels N; Nemeth AH; Smith M; Barnicoat A; Ewenczyk C; Méneret A; Roze E; Keren B; Mignot C; Beroud C; Acosta F; Nowak C; Wilson WG; Steel D; Capuano A; Vidailhet M; Lin JP; Tranchant C; Cif L; Doummar D; Anheim M
    Mov Disord; 2022 Jul; 37(7):1547-1554. PubMed ID: 35722775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Movement disorder in
    Feng H; Sjögren B; Karaj B; Shaw V; Gezer A; Neubig RR
    Neurology; 2017 Aug; 89(8):762-770. PubMed ID: 28747448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Course of Six Children With GNAO1 Mutations Causing a Severe and Distinctive Movement Disorder.
    Ananth AL; Robichaux-Viehoever A; Kim YM; Hanson-Kahn A; Cox R; Enns GM; Strober J; Willing M; Schlaggar BL; Wu YW; Bernstein JA
    Pediatr Neurol; 2016 Jun; 59():81-4. PubMed ID: 27068059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic spectrum of GNAO1 variants: epileptic encephalopathy to involuntary movements with severe developmental delay.
    Saitsu H; Fukai R; Ben-Zeev B; Sakai Y; Mimaki M; Okamoto N; Suzuki Y; Monden Y; Saito H; Tziperman B; Torio M; Akamine S; Takahashi N; Osaka H; Yamagata T; Nakamura K; Tsurusaki Y; Nakashima M; Miyake N; Shiina M; Ogata K; Matsumoto N
    Eur J Hum Genet; 2016 Jan; 24(1):129-34. PubMed ID: 25966631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal epileptic encephalopathy caused by de novo GNAO1 mutation misdiagnosed as atypical Rett syndrome: Cautions in interpretation of genomic test results.
    Gerald B; Ramsey K; Belnap N; Szelinger S; Siniard AL; Balak C; Russell M; Richholt R; De Both M; Claasen AM; Schrauwen I; Huentelman MJ; Craig DW; Rangasamy S; Narayanan V
    Semin Pediatr Neurol; 2018 Jul; 26():28-32. PubMed ID: 29961512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GNAO1-related neurodevelopmental disorder: Literature review and caregiver survey.
    JoJo Yang QZ; Porter BE; Axeen ET
    Epilepsy Behav Rep; 2023; 21():100582. PubMed ID: 36654732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Encephalopathy GNAO1].
    Bobylova MY; Volkov IV; Gumennik EV; Rachmanina OA; Abramov MO; Volkova OK; Bayborina TS; Petrukhin AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(1):122-130. PubMed ID: 36719128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice with
    Larrivee CL; Feng H; Quinn JA; Shaw VS; Leipprandt JR; Demireva EY; Xie H; Neubig RR
    J Pharmacol Exp Ther; 2020 Apr; 373(1):24-33. PubMed ID: 31907305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic modeling of GNAO1 disorder delineates mechanisms of Gαo dysfunction.
    Wang D; Dao M; Muntean BS; Giles AC; Martemyanov KA; Grill B
    Hum Mol Genet; 2022 Feb; 31(4):510-522. PubMed ID: 34508586
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.